TRANSFORMED FOLLICULAR LYMPHOMA
Clinical trials for TRANSFORMED FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail of drugs shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis phase 2 trial is testing several new combinations of drugs to treat aggressive B-cell lymphoma that has come back or not responded to standard treatment. The study involves 129 participants and compares the new combinations to standard therapy. The main goal is to see if the…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
New hope for tough lymphoma: early trial combines novel drug with standard care
Disease control OngoingThis study tests a new drug given together with standard chemotherapy (R-GDP) for people with aggressive B-cell lymphoma that has come back or not responded to treatment. The main goal is to find the highest dose that is safe and does not cause severe side effects. About 40 adult…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
New hope for aggressive lymphoma: targeted combo shows promise in early trial
Disease control OngoingThis study tests a new drug called glofitamab added to standard chemotherapy (R-CHOP) for people with a fast-growing type of lymphoma that has a high risk of coming back. The goal is to see if the combination is safe and helps more patients achieve complete remission. About 46 ad…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC